STENOCARE A/S Logo

STENOCARE A/S

Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.

STENO | ST

Overview

Corporate Details

ISIN(s):
DK0061078425
LEI:
549300NCH67H3GA28R82
Country:
Denmark
Address:
Nyholmsvej 4, 8930 Randers NØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

STENOCARE A/S is a pharmaceutical company that develops, produces, and distributes prescription-based medical cannabis products. The company focuses on providing pharmaceutical-grade cannabis oils, ensuring quality and uniformity for patients treating various conditions. A pioneer in the field, STENOCARE was the first to supply approved medical cannabis oil products in several Nordic countries. It operates under strict regulatory controls, holding permits for cultivation, handling, and distribution. The company serves patients and doctors across markets in Northern Europe and Australia, aiming to enhance quality of life through well-documented and accessible medical cannabis solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all STENOCARE A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for STENOCARE A/S

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for STENOCARE A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.